Department of Nephrology and Hypertension (F.J.W., K.X.K., K.S., M.S., R. Schmieder, K.F.H., M.S.W.), University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Germany.
Center for Human Genetics, Cliniques universitaires Saint-Luc, Brussels, Belgium (E.O.).
Hypertension. 2024 Sep;81(9):1857-1868. doi: 10.1161/HYPERTENSIONAHA.124.22806. Epub 2024 Jul 15.
Autosomal recessive renal tubular dysgenesis is a rare, usually fatal inherited disorder of the renin-angiotensis system (RAS). Herein, we report an adolescent individual experiencing an unknown chronic kidney disease and aim to provide novel insights into disease mechanisms.
Exome sequencing for a gene panel associated with renal disease was performed. The RAS was assessed by comprehensive biochemical analysis in blood. Renin expression was determined in primary tubular cells by quantitative polymerase chain reaction and in situ hybridization on kidney biopsy samples. Allele frequencies of heterozygous and biallelic deleterious variants were determined by analysis of the Genomics England 100,000 Genomes Project.
The patient was delivered prematurely after oligohydramnios was detected during pregnancy. Postnatally, he recovered from third-degree acute kidney injury but developed chronic kidney disease stage G3b over time. Exome sequencing revealed a previously reported pathogenic homozygous missense variant, p.(Arg375Gln), in the (angiotensinogen) gene. Blood AGT concentrations were low, but plasma renin concentration and gene expression in kidney biopsy, vascular, and tubular cells revealed strong upregulation of renin. Angiotensin II and aldosterone in blood were not abnormally elevated.
Renal tubular dysgenesis may present as chronic kidney disease with a variable phenotype, necessitating broad genetic analysis for diagnosis. Functional analysis of the RAS in a patient with mutation revealed novel insights regarding compensatory upregulation of renin in vascular and tubular cells of the kidney and in plasma in response to depletion of AGT substrate as a source of Ang II (similarly observed with hepatic silencing for the treatment of hypertension).
常染色体隐性遗传性肾小管发育不良是一种罕见的、通常致命的肾素血管紧张素系统(RAS)遗传性疾病。在此,我们报告一例患有未知慢性肾脏病的青少年病例,旨在为疾病机制提供新的见解。
对与肾脏疾病相关的基因进行外显子组测序。通过全面的血液生化分析评估 RAS。通过定量聚合酶链反应和肾脏活检样本的原位杂交确定原代肾小管细胞中的肾素表达。通过分析英国基因组 10 万基因组计划中的杂合和纯合有害变异等位基因频率来确定杂合和纯合有害变异等位基因频率。
该患者在妊娠期间因羊水过少而早产。出生后,他从三度急性肾损伤中恢复过来,但随着时间的推移,他发展为慢性肾脏病 G3b 期。外显子组测序显示,在 (血管紧张素原)基因中存在先前报道的致病性纯合错义变异 p.(Arg375Gln)。血液 AGT 浓度较低,但血浆肾素浓度和肾脏活检、血管和肾小管细胞中的基因表达显示肾素强烈上调。血液中的血管紧张素 II 和醛固酮没有异常升高。
肾小管发育不良可能表现为慢性肾脏病,其表型具有变异性,需要进行广泛的基因分析以进行诊断。对 突变患者的 RAS 功能分析提供了新的见解,即肾血管和肾小管细胞以及血浆中的肾素在 AGT 底物作为 Ang II 来源耗竭时(如肝 沉默治疗高血压时也观察到)会发生代偿性上调。